Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol

Fig. 3

Relationship between a larger dimension of non-enhancing area in preoperative SMA-CEUS and tumour response after TACE. A, B-mode ultrasound showed a hypoechoic HCC lesion located in segment 4, which was 3.3 × 3.5 cm (indicated by the arrow). B, Preoperative SMA-CEUS showed that a significant larger dimension (3.9 × 4.6 cm) of non-enhancing area (triangle shown) than the size in B-mode ultrasound. C, Postoperative abdominal contrast-enhanced MRI showed that the tumour response should be defined as stable disease (indicated by the arrow). TACE = transarterial chemoembolization, HCC = hepatocellular carcinoma; CEUS = contrast-enhanced ultrasound; SMA-CEUS = superior mesenteric artery contrast-enhanced ultrasound

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us